Published 1995
| Version v1.0.0
Journal Article
Open
5-Hydroxytryptophan in Friedreichs Ataxia
- Creators
- Millichap, J. Gordon
Abstract
The effect of the levorotatory form of 5-hydroxytryptophan (approx 1 gm/day/orally) on cerebellar symptoms in 26 patients with Friedreichs ataxia was evaluated in a double-blind drug-placebo study by the Ataxia Research Center, Hopital Neurologique, Lyon and 11 other research hospitals in France.
Files
PNB-9-44-b.pdf
Files
(2.4 MB)
Name | Size | Download all |
---|---|---|
md5:f60cd331a7a79f0c2e5e215ee4324b04
|
2.4 MB | Preview Download |
Additional details
- Other
- PNB-9-44-b
- Created
-
1995When the item was originally created.